Dow Up 0.52% Nasdaq Up 2.05%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
4.78 Up 0.17(3.69%) 1:04PM EST - Nasdaq Real Time Price
Prev Close:4.61
Open:4.77
Bid:4.73 x 2800
Ask:4.74 x 1000
1y Target Est:7.88
Beta:1.64489
Next Earnings Date:23-Feb-16ARIA Earnings announcement
Day's Range:4.59 - 4.80
52wk Range:4.48 - 10.07
Volume:1,251,886
Avg Vol (3m):3,454,390
Market Cap:904.82M
P/E (ttm):N/A
EPS (ttm):-0.94
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIAUp 3.69%904.82M
PFEUp 2.59%184.31B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.24
Quarterly EPS Est (Dec-15) :-0.31
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback